EDP Sciences logo
Subscriber Authentication Point
rechercher
Menu
Accueil Tous les numéros Volume 208 / Numéro 2 (2014) Biologie Aujourd'hui, 208 2 (2014) 97-107 References
Free Access
Issue
Biologie Aujourd'hui
Volume 208, Number 2, 2014
Page(s) 97 - 107
Section Signalisation de l’insuline et insulino-résistance
DOI https://doi.org/10.1051/jbio/2014014
Published online 8 septembre 2014
  • Bertola A., Ciucci T., Rousseau D., Bourlier V., Duffaut C., Bonnafous S., Blin-Wakkach C., Anty R., Iannelli A., Gugenheim J., Tran A., Bouloumié A., Gual P., Wakkach A., Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes, 2012, 61, 2238–2247. [CrossRef] [PubMed] [Google Scholar]
  • Biddinger S.B., Kahn C.R., From Mice to Men: Insights into the Insulin Resistance Syndromes. Annu Rev Physiol, 2006, 68, 123–158. [Google Scholar]
  • Bost F., Aouadi M., Caron L., Even P., Belmonte N., Prot M., Dani C., Hofman P., Pages G., Pouysségur J., Le Marchand-Brustel Y., Binétruy B., The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes, 2005, 54, 402–411. [CrossRef] [PubMed] [Google Scholar]
  • Boura-Halfon S., Zick Y., Serine kinases of insulin receptor substrate proteins. Vitam Horm, 2009, 80, 313–349. [CrossRef] [PubMed] [Google Scholar]
  • Bouzakri K., Karlsson H.K., Vestergaard H., Madsbad S., Christiansen E., Zierath J.R., IRS-1 Serine Phosphorylation and Insulin Resistance in Skeletal Muscle From Pancreas Transplant Recipients. Diabetes, 2006, 55, 785–791. [CrossRef] [PubMed] [Google Scholar]
  • Burcelin R. Regulation of metabolism: a cross talk between gut microbiota and its human host. Physiology (Bethesda), 2012, 27, 300–307. [CrossRef] [PubMed] [Google Scholar]
  • Carlson C.J., Rondinone C.M., Pharmacological inhibition of p38 MAP kinase results in improved glucose uptake in insulin-resistant 3T3-L1 adipocytes. Metabolism, 2005, 54, 895–901. [CrossRef] [PubMed] [Google Scholar]
  • Ceppo F., Berthou F., Jager J., Dumas K., Cormont M., Tanti J.-F., Implication of the Tpl2 kinase in inflammatory changes and insulin resistance induced by the interaction between adipocytes and macrophages. Endocrinology, 2014, 155, 951–964. [CrossRef] [PubMed] [Google Scholar]
  • Dali-Youcef N., Mecili M., Ricci R., Andres E., Metabolic inflammation: connecting obesity and insulin resistance. Ann Med, 2013, 45, 242–253. [CrossRef] [PubMed] [Google Scholar]
  • Donath M.Y., Shoelson S.E., Type 2 diabetes as an inflammatory disease. Nat Rev Immunol, 2011, 11, 98–107. [CrossRef] [PubMed] [Google Scholar]
  • Dumitru C.D., Ceci J.D., Tsatsanis C., Kontoyiannis D., Stamatakis K., Lin J.H., Patriotis C., Jenkins N.A., Copeland N.G., Kollias G., Tsichlis P. N., TNF-alpha induction by LPS is regulated post-transcriptionally via a Tpl2/ERK-dependent pathway. Cell, 2000, 103, 1071–1083. [CrossRef] [PubMed] [Google Scholar]
  • Emanuelli B., Eberlé D., Suzuki R., Kahn C.R., Overexpression of the dual-specificity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance. Proc Natl Acad Sci USA, 2008, 105, 3545–3550. [CrossRef] [Google Scholar]
  • Forsythe L.K., Wallace J.M., Livingstone M.B., Obesity and inflammation: the effects of weight loss. Nutr Res Rev, 2008, 21, 117–133. [CrossRef] [PubMed] [Google Scholar]
  • Fujishiro M., Gotoh Y., Katagiri H., Sakoda H., Ogihara T., Anai M., Onishi Y., Ono H., Funaki M., Inukai K., Fukushima Y., Kikuchi M., Oka Y., Asano, T., MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. J Biol Chem, 2001, 276, 19800–19806. [CrossRef] [PubMed] [Google Scholar]
  • Fujishiro M., Gotoh Y., Katagiri H., Sakoda H., Ogihara T., Anai M., Onishi Y., Ono H., Abe M., Shojima N., Fukushima Y., Kikuchi M., Oka Y., Asano T., Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. Mol Endocrinol, 2003, 17, 487–497. [CrossRef] [PubMed] [Google Scholar]
  • Gallagher E.J., LeRoith D., Insulin, insulin resistance, obesity, and cancer. Curr Diab Rep, 2010, 10, 93–100. [CrossRef] [PubMed] [Google Scholar]
  • Gantke T., Sriskantharajah S., Ley S.C., Regulation and function of TPL-2, an IkappaB kinase-regulated MAP kinase kinase kinase. Cell Res, 2011, 21, 131–145. [CrossRef] [PubMed] [Google Scholar]
  • Gantke T., Sriskantharajah S., Sadowski M., Ley S.C. IkappaB kinase regulation of the TPL-2/ERK MAPK pathway. Immunol Rev, 2012, 246, 168–182. [CrossRef] [PubMed] [Google Scholar]
  • Gregor M.F., Hotamisligil, G.S., Inflammatory mechanisms in obesity. Annu Rev Immunol, 2011, 29, 415–445. [CrossRef] [PubMed] [Google Scholar]
  • Gual P., Le Marchand-Brustel Y., Tanti, J.-F., Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie, 2005, 87, 99–109. [CrossRef] [PubMed] [Google Scholar]
  • Han M.S., Jung D.Y., Morel C., Lakhani S.A., Kim J.K., Flavell R.A., Davis, R.J., JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science, 2013, 339, 218–222. [CrossRef] [PubMed] [Google Scholar]
  • Henstridge D.C., Bruce C.R., Pang C.P., Lancaster G.I., Allen T.L., Estevez E., Gardner T., Weir J.M., Meikle P.J., Lam K.S., Xu A., Fujii N., Goodyear L.J., Febbraio M.A., Skeletal muscle-specific overproduction of constitutively activated c-Jun N-terminal kinase (JNK) induces insulin resistance in mice. Diabetologia, 2012, 55, 2769–2778. [CrossRef] [PubMed] [Google Scholar]
  • Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., Hotamisligil G.S., A central role for JNK in obesity and insulin resistance. Nature, 2002, 420, 333–336. [CrossRef] [PubMed] [Google Scholar]
  • Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M., IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-apha- and obesity-induced insulin resistance. Science, 1996, 271, 665–668. [CrossRef] [PubMed] [Google Scholar]
  • Jager J., Grémeaux T., Cormont M., Le Marchand-Brustel Y., Tanti J.-F., Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology, 2007, 148, 241–251. [CrossRef] [PubMed] [Google Scholar]
  • Jager J., Grémeaux T., Gonzalez T., Bonnafous S., Debard C., Laville M., Vidal H., Tran A., Gual P., Le Marchand-Brustel Y., Cormont M., Tanti, J.-F., The Tpl2 kinase is up-regulated in adipose tissue in obesity and may mediate IL-1{beta} and TNF- {alpha} effects on ERK activation and lipolysis. Diabetes, 2010, 59, 61–70. [CrossRef] [PubMed] [Google Scholar]
  • Jager J., Corcelle V., Grémeaux T., Laurent K., Waget A., Pagès G., Binétruy B., Le Marchand-Brustel Y., Burcelin R., Bost F., Tanti, J.-F., Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity. Diabetologia, 2011, 54, 180–189. [CrossRef] [PubMed] [Google Scholar]
  • Kaddai V., Le Marchand-Brustel Y., Cormont M., Rab proteins in endocytosis and Glut4 trafficking. Acta Physiol (Oxf), 2008, 192, 75–88. [CrossRef] [PubMed] [Google Scholar]
  • Kaddai V., Gonzalez T., Keslair F., Grémeaux T., Bonnafous S., Gugenheim J., Tran A., Gual P., Le Marchand-Brustel Y., Cormont M., Rab4b is a small GTPase involved in the control of the glucose transporter GLUT4 localization in adipocyte. PLoS One, 2009, 4, e5257. [CrossRef] [PubMed] [Google Scholar]
  • Keshet Y., Seger R., The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol Biol, 2010, 661, 3–38. [CrossRef] [PubMed] [Google Scholar]
  • Lancaster G.I., Kowalski G.M., Estevez E., Kraakman M.J., Grigoriadis G., Febbraio M.A., Gerondakis, S., Banerjee A., Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease. PLoS One, 2012, 7, e39100. [CrossRef] [PubMed] [Google Scholar]
  • Lebrun P., Van Obberghen E. SOCS proteins causing trouble in insulin action. Acta Physiol (Oxf), 2008, 192, 29–36. [CrossRef] [PubMed] [Google Scholar]
  • Lee S.J., Pfluger P.T., Kim J.Y., Nogueiras R., Duran A., Pagès G., Pouysségur J., Tschop M.H., Diaz-Meco M.T., Moscat J., A functional role for the p62-ERK1 axis in the control of energy homeostasis and adipogenesis. EMBO Rep, 2010, 11, 226–232. [CrossRef] [PubMed] [Google Scholar]
  • Leto D., Saltiel A.R., Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol, 2012, 13, 383–396. [CrossRef] [PubMed] [Google Scholar]
  • Lolmède K., Duffaut C., Zakaroff-Girard A., Bouloumié A., Immune cells in adipose tissue: key players in metabolic disorders. Diabetes Metab, 2011, 37, 283–290. [CrossRef] [PubMed] [Google Scholar]
  • Mari M., Monzo P., Kaddai V., Keslair F., Gonzalez T., Le Marchand-Brustel Y., Cormont M., The Rab4 effector Rabip4 plays a role in the endocytotic trafficking of Glut 4 in 3T3-L1 adipocytes. J Cell Sci, 2006, 119, 1297–1306. [CrossRef] [PubMed] [Google Scholar]
  • Morgan B.J., Chai S.Y., Albiston A.L., GLUT4 associated proteins as therapeutic targets for diabetes. Recent Pat Endocr Metab Immune Drug Discov, 2011, 5, 25–32. [CrossRef] [PubMed] [Google Scholar]
  • Nicholson J.K., Holmes E., Kinross J., Burcelin R., Gibson G., Jia W., Pettersson S. Host-gut microbiota metabolic interactions. Science, 2012, 336, 1262–1267. [CrossRef] [PubMed] [Google Scholar]
  • Perfield J.W., 2nd, Lee Y., Shulman G.I., Samuel V.T., Jurczak M.J., Chang E., Xie C., Tsichlis P.N., Obin M.S., Greenberg A.S., Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance. Diabetes, 2011, 60, 1168–1176. [CrossRef] [PubMed] [Google Scholar]
  • Rask-Madsen C., Kahn, C.R., Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler Thromb Vasc Biol, 2012, 32, 2052–2059. [CrossRef] [PubMed] [Google Scholar]
  • Regazzetti C., Peraldi P., Grémeaux T., Najem-Lendom R., Ben-Sahra I., Cormont M., Bost F., Le Marchand-Brustel Y., Tanti J.-F., Giorgetti-Peraldi S., Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes, 2009, 58, 95–103. [CrossRef] [PubMed] [Google Scholar]
  • Rodriguez A., Duran A., Selloum M., Champy M.-F., Diez-Guerra F.J., Flores J.M., Serrano M., Auwerx J., Diaz-Meco M.T., Moscat J., Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab, 2006, 3, 211–222. [CrossRef] [PubMed] [Google Scholar]
  • Sabio G., Davis, R.J., cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance. Trends Biochem Sci, 2010, 35, 490–496. [CrossRef] [PubMed] [Google Scholar]
  • Shoelson S.E., Lee J., Yuan M., Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord, 2003, 27 3, S49–S52. [CrossRef] [PubMed] [Google Scholar]
  • Solinas G., Vilcu C., Neels J.G., Bandyopadhyay G.K., Luo J.L., Naugler W., Grivennikov S., Wynshaw-Boris A., Scadeng M., Olefsky J.M., Karin, M., JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab, 2007, 6, 386–397. [CrossRef] [PubMed] [Google Scholar]
  • Sun S., Ji Y., Kersten S., Qi L., Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr, 2012, 32, 261–286. [CrossRef] [PubMed] [Google Scholar]
  • Taniguchi C.M., Emanuelli B., Kahn, C.R., Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol, 2006, 7, 85–96. [CrossRef] [PubMed] [Google Scholar]
  • Tanti J. -F., Jager, J., Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr Opin Pharmacol, 2009, 9, 753–762. [CrossRef] [PubMed] [Google Scholar]
  • Tanti J.-F., Grémeaux T., Van Obberghen E., Le Marchand-Brustel Y., Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem, 1994, 269, 6051–6057. [PubMed] [Google Scholar]
  • Tanti, J.-F., Ceppo F., Jager J., Berthou F., Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol (Lausanne), 2013, 3, 181. [PubMed] [Google Scholar]
  • Vallerie S.N., Furuhashi M., Fucho R., Hotamisligil G.S., A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity. PLoS ONE, 2008, 3, e3151. [CrossRef] [PubMed] [Google Scholar]
  • Vernia S., Cavanagh-Kyros J., Barrett T., Jung D.Y., Kim J.K., Davis R. J., Diet-induced obesity mediated by the JNK/DIO2 signal transduction pathway. Genes Dev, 2013, 27, 2345–2355. [CrossRef] [PubMed] [Google Scholar]
  • White M.F., IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab, 2002, 283, E413–422. [PubMed] [Google Scholar]
  • Wood I.S., de Heredia F.P., Wang B., Trayhurn P., Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc, 2009, 68, 370–377. [CrossRef] [PubMed] [Google Scholar]
  • Yang R., Trevillyan J.M., c-Jun N-terminal kinase pathways in diabetes. Int J Biochem Cell Biol, 2008, 40, 2702–2706. [CrossRef] [PubMed] [Google Scholar]
  • Zhang X., Xu A., Chung S.K., Cresser J.H., Sweeney G., Wong R.L., Lin A., Lam, K.S., Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice. Diabetes, 2011, 60, 486–495. [CrossRef] [PubMed] [Google Scholar]
  • Zick Y., Role of Ser/Thr kinases in the uncoupling of insulin signaling. Int J Obes Relat Metab Disord, 2003, 27, S56–S60. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.